Christopher C. Nessel

1 ta ish

Johnson & Johnson (United States)

1. Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

   Manesh R. Patel, Kenneth W. Mahaffey, Jyotsna Garg +13

   Maqola20112 iqtibos

   ABIABI:AkademIndex/2026.other.696774